1 - Fundeni Clinical Institute, Bucharest, Romania
2 - Titu Maiorescu University - Faculty of Medicine, Bucharest, Romania
3 - University Emergency Hospital, Bucharest, Romania
4 - Carol Davila University of Medicine and Pharmacy, Bucharest, Romania 43
Received: February 12, 2017
Accepted: June 10, 2017
Introduction: The gastrointestinal stromal tumors (GIST) are dominated by KIT and PDGFRA mutation. The immunohistochemical detection of CD117, a protein express by KIT gene, is essential for the diagnosis and those that are negative always represented a diagnostic challenge Case reports: In this article we present a series of 4 cases of CD117 negative GIST tumors, diagnosed and surgically resected in Fundeni Clinical Institute and an overview of the histogenesis, diagnostic problems and management of c-kit negative GIST. All patients were males and the tumors were located in the stomach and small bowel. Conclusion: It is important for the pathologists to beware of the fact that a CD117 negative in the context of a typical morphological appearance does not exclude a GIST tumor and also the oncologist must be aware not to exclude the therapy with imatinib based on the negativity of CD117.
Iorgescu, A.C., Herlea, V., Mustafa, E.S., Pechianu, C., & Procop, A. (2025). Diagnostic difficulties in c-kit negative gastrointestinal stromal tumors: report of four cases. Romanian Journal of Military Medicine, 120(3), 43-50.
Iorgescu AC, Herlea V, Mustafa ES, Pechianu C, Procop A. Diagnostic difficulties in c-kit negative gastrointestinal stromal tumors: report of four cases. Rom J Mil Med. 2025;120(3):43-50.
Iorgescu, A.C., Herlea, V., Mustafa, E.S., Pechianu, C. & Procop, A. 2025, 'Diagnostic difficulties in c-kit negative gastrointestinal stromal tumors: report of four cases', Romanian Journal of Military Medicine, vol. 120, no. 3, pp. 43-50.